Ocrelizumab 67643-7000-02
- Manufacturer
- Lonza Biologics, Inc.
- Dosage Form
- Liquid
- Product Type
- Drug For Further Processing
- Marketing Start
- March 28, 2017
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ocrelizumab | 55 mg/mL |
Selected Package
67643-7000-02Selected300000 mL in 1 TANK (67643-7000-2)
Other packages for this product(1)
120000 mL in 1 TANK (67643-7000-1)